Comparison of ciprofloxacin, cotrimoxazole, and doxycycline on Klebsiella pneumoniae: Time-kill curve analysis
Open Access
- 5 November 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 84, 104841
Abstract
Antibiotic resistance is a significant problem in the world, so optimization of antibiotic use is needed. Klebsiella pneumoniae is a Gram-negative bacterium that causes bacteremia, sepsis, UTIs, pneumonia, nosocomial infections and ESBL-producing bacterium. ciprofloxacin, cotrimoxazole, and doxycycline are broad-spectrum antibiotics, including in WHO essential drugs. The study tested antibiotics that most effectively inhibited Klebsiella pneumoniae non-ESBL, Klebsiella pneumoniae ESBL invitro with time-kill curve analysis. This experiment used Klebsiella pneumoniae ATCC isolates, stored clinical isolates of Klebsiella pneumoniae non-ESBL, Klebsiella pneumoniae ESBL, and the control group. Isolates other than control were challenged with ciprofloxacin, cotrimoxazole, and doxycycline oral preparations with concentrations of 1, 2, 4 MIC at 0, 2, 4, 6, 8, 24 h. At each hour, the bacteria were cultured, incubated, calculated the number of colonies. The results were analyzed with time-kill curve and tested statistics. Statistical analysis used included ANOVA, post-Hoc, Mann Whitney, and Kruskal Willis tests with p < 0.05. Ciprofloxacin, cotrimoxazole, and doxycycline in this study had inhibition effects on Klebsiella pneumoniae non-ESBL and Klebsiella pneumoniae ESBL. Ciprofloxacin had the best inhibitory effect. Statistically, the most meaningful differences of antibiotics in ciprofloxacin and cotrimoxazole at four and 24 h (p < 0.001), in concentrations of 1 MIC and 4 MIC at 2 h (p < 0.001), and in Klebsiella pneumoniae ESBL and Klebsiella pneumoniae ATCC at 8 h (p = 0.024). Ciprofloxacin is the best antibiotic to inhibit the growth of Klebsiella pneumoniae non-ESBL and Klebsiella pneumoniae ESBL compared to cotrimoxazole and doxycycline. The inhibitory effect increases with an increase in concentration.Keywords
This publication has 22 references indexed in Scilit:
- Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacinJournal of Microbiology, Immunology and Infection, 2019
- Successful Doxycycline Therapy in a Patient With Escherichia coli and Multidrug-Resistant Klebsiella pneumoniae Urinary Tract InfectionJournal of Pharmacy Practice, 2016
- Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problemTherapeutic Advances in Drug Safety, 2014
- Cotrimoxazole - optimal dosing in the critically illAnnals of Intensive Care, 2014
- High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in AsiaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Do Indonesian community pharmacy workers respond to antibiotics requests appropriately?Tropical Medicine & International Health, 2011
- Pharmacokinetics and Pharmacodynamics of Antibacterial AgentsInfectious Disease Clinics of North America, 2009
- Comparative time–kill study of doxycycline, tigecycline, sulbactam, and imipenem against several clones of Acinetobacter baumanniiDiagnostic Microbiology and Infectious Disease, 2008
- In vitro antibacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller-Hinton brothDiagnostic Microbiology and Infectious Disease, 2007
- Relationship between ciprofloxacin resistance and extended-spectrum β-lactamase production in Escherichia coli and Klebsiella pneumoniae strainsClinical Microbiology and Infection, 2004